SMi Group is thrilled to present the 7th annual conference, Biosimilars Europe, taking place on 29th & 30th September 2016 in Central London, UK. Gathering an audience of principle scientists and regulatory experts involved in biotechnology and compliance, Biosimilars Europe 2016 will provide a perfect platform to discuss global market developments and strategies to market access.
Created with a top panel of industry thought leaders, this year's event will capture expert insight by honing in on the biosimilar product life-cycle from early stage developments, protein characterisation, and pricing & reimbursement; through to emerging markets and global developments.
Join us this autumn to arm yourself with the key requirements and tools for successful market entry through strategic direction on commercialisation; insight into potential therapeutic areas; and guidance on product quality assessment (PQA) in biosimilar development.
OUR NOTABLE SPEAKER LINE-UP WILL INCLUDE:
WHY YOU NEED TO BE THERE IN 2016:
PREVIOUS ATTENDEE TESTIMONIALS:
"Really wide range of topics" - Kantar Health
"Rich in information and quality speakers" - Globyz Pharma
"Great discussions, networking and education" - Apobiologix
"Interesting mix of scientists, legal and commercial folk" - Allergan
"Impressive - beat my expectations" – Teva
For further details or to register, visit the website at www.biosimilars-europe.com or contact Fateja Begum on +44 (0)20 7827 6184, email fbegum@smi-online.co.uk
29 Sep 2016
30 Sep 2016
Holiday Inn Kensington Forum
97 Cromwell Road
United Kingdom
English en